ScripsAmerica Inc. (SCRCQ)

[coolerheadsprevail]

TYSONS CORNER, VA / ACCESSWIRE / January 5, 2014 / ScripsAmerica, Inc. (OTCBB: SCRC) today announced that its wholly owned subsidiary, Main Avenue Pharmacy, reported $5,280,402 in approved orders during the month of December 2014.

So now we now all the monthly approved orders for Q4’14:

OCT = $5.619M
NOV = $5.258M
DEC = $5.280M
---------------------
Q4 = $16.157M (preliminary unadjusted revenues)


ADD $3.609M (Q3’s backlog which was shipped in OCT’14, so it now qualifies for recognition as revenues)

SUBTRACT $3.407M (estimated Q4 backlog, assuming same 20-day backlog as existed at the end of both Q2 and Q3; if the # of days backlog changes as of 12/31/14, then this estimated $3.407M number obviously will change as well)
---------------------

$16.359M (Estimated Q4’14 Net Revenues from Main Ave ONLY)
===========

Assuming that Main Ave comprises 99% of SCRC financial results, then based upon Q3’s 11.9% net income ratio (as a percentage of Main Ave net revenues) – which also assumes that all other operating and non-operating expenses remain consistent with Q3 – then this projects out to Q4 net income of $1.952M.

Certainly, if SCRC was able to get selling expenses under control and below 65%, then that will only add to the net income (and significantly).

This $1.952M net income for Q4’14 translates to EPS of .0142 (.0117 on a fully-diluted basis, which I recommend be the share count you use). And on an annualized basis, this translates to EPS of .0570 (.0468 fully-diluted).

Plug these numbers into whatever models you use to determine your entry/exit points and make your own decisions on how best to make money for yourselves. Buy, hold, add, sell, trade, makes no difference to me. Just make well-informed decisions and calculate the true risks properly using accurate data points.

Continued GLTA…